Isabel Krsnik

11PUBLICATIONS
74CO-AUTHORS
Gene and molecular therapyEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|May 11, 2024
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.

Rafael Ríos-Tamayo, Ramón Lecumberri, María Teresa Cibeira

|Jul 28, 2023
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.

Laura Rosiñol, Albert Oriol, Rafael Ríos

|Mar 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.

Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig

|Feb 14, 2022
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.

Noemí Puig, María-Teresa Contreras, Cristina Agulló

|Jun 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development.

Daniel Alameda, Ibai Goicoechea, Marco Vicari

Pageof 2

Frequent Collaborators

7 joint publications

Juan-Jose Lahuerta

7 joint publications

Joaquín Martínez-López

7 joint publications

Albert Oriol

7 joint publications

Valentín Cabañas